NobleOak Life Limited (ASX:NOL)
Australia · Delayed Price · Currency is AUD | Market Cap | 126.05M -6.5% |
| Revenue (ttm) | 156.54M +26.3% |
| Net Income | 14.11M +98.2% |
| EPS | 0.15 +90.6% |
| Shares Out | 93.03M |
| PE Ratio | 9.17 |
| Forward PE | 5.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,055 |
| Open | 1.400 |
| Previous Close | 1.395 |
| Day's Range | 1.355 - 1.400 |
| 52-Week Range | 1.050 - 1.540 |
| Beta | 0.11 |
| Analysts | Strong Buy |
| Price Target | 3.15 (+132.47%) |
| Est. Earnings | Nov 26, 2026 |
About NobleOak Life
NobleOak Life Limited engages in the manufacture and distribution of life insurance products in Australia. The company offers life, income protection, total and permanent disability, death, trauma, business expenses, and self managed super fund insurance plans. It sells its insurance products through direct-to-market and strategic partner channels. The company was formerly known as United Ancient Order of Druids Friendly Society of NSW and changed its name to NobleOak Life Limited in 2011. NobleOak Life Limited was founded in 1861 and is headqu... [Read more]
Financial Performance
In fiscal year 2026, NobleOak Life's revenue was 156.54 million, an increase of 26.26% compared to the previous year's 123.99 million. Earnings were 14.11 million, an increase of 98.24%.
Financial StatementsAnalyst Summary
According to 2 analysts, the average rating for NOL stock is "Strong Buy." The 12-month stock price target is $3.15, which is an increase of 132.47% from the latest price.
News
NobleOak Life Earnings Call Transcript: H2 2026
In-force premiums grew 18% to AUD 549 million and underlying NPAT rose 15% to AUD 21.1 million, with strong performance across both direct and strategic partner segments. FY27 guidance targets over 12% in-force premium growth and 10% NPAT growth, supported by new partnerships, automation, and a robust capital position.
NobleOak Life Annual report: H2 2026
NobleOak Life has published its H2 2026 annual report on August 27, 2026.
NobleOak Life Earnings release: H2 2026
NobleOak Life released its H2 2026 earnings on August 27, 2026, summarizing the period's financial results.
NobleOak Life Slides: H2 2026
NobleOak Life has posted slides in relation to its H2 2026 quarterly earnings report, which was published on August 27, 2026.
NobleOak Life Earnings Call Transcript: H1 2026
Strong in-force premium and NPAT growth were achieved, with market share gains in both direct and partner channels. AI adoption and new partnerships, including nib and NEOS, support future growth, while capital remains robust and guidance for FY26 is reaffirmed.
NobleOak Life Quarterly report: H1 2026
NobleOak Life has published its H1 2026 quarterly earnings report on February 26, 2026.
NobleOak Life Slides: H1 2026
NobleOak Life has posted slides in relation to its H1 2026 quarterly earnings report, which was published on February 26, 2026.
NobleOak Life Earnings release: H1 2026
NobleOak Life released its H1 2026 earnings on February 26, 2026, summarizing the period's financial results.
NobleOak Life Transcript: AGM 2025
The AGM highlighted strong financial growth, with in-force premiums up 20% and underlying NPAT up 22%. Strategic initiatives include transitioning to a life company structure, ongoing tech investment, and new product launches. No dividend was declared, with capital focused on growth.
NobleOak Life Slides: FY 2025
NobleOak Life has posted slides in relation to its FY 2025 quarterly earnings report, which was published on November 20, 2025.